Beyond DNA Sequencing in Space: Current and Future Omics Capabilities of the Biomolecule Sequencer Payload by Wallace, Sarah
Beyond DNA Sequencing in Space: 
Current and Future Omics Capabilities of the 
Biomolecule Sequencer Payload
Sarah Wallace, Ph.D.
NASA Johnson Space Center 
Microbiology Laboratory 
Omics Workshop
April 11, 2017
sarah.wallace@nasa.gov
https://ntrs.nasa.gov/search.jsp?R=20170004415 2019-08-29T23:01:12+00:00Z
Why a DNA Sequencer in Space?
Why do we need a DNA sequencer to support the human exploration of space? 
• Operational environmental monitoring 
• Identification of contaminating microbes
• Infectious disease diagnosis
• Reduce down mass (sample return for environmental monitoring, crew health, etc.)
• Research 
• Human
• Animal
• Microbes/Cell lines
• Plant
• Med Ops
• Response to countermeasures 
• Radiation
• Real-time analysis can influence medical intervention
• Support astrobiology science investigations 
• Technology superiorly suited to in situ nucleic acid-based life detection
• Functional testing for integration into robotics for extraplanetary exploration mission
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Biomolecule Sequencer Payload 
• Would be the first device to assess the capability of 
DNA sequencing in the microgravity environment of 
space
• Enabled by the MinION™, developed by Oxford 
Nanopore Technologies
• COTS miniature DNA Sequencer
• 3 ¾ x 1 ¼ x 5/8 inches
• Less than 120 grams (with USB cable)
• Powered via USB connection
• Capable of DNA, RNA, and protein sequencing
• Manifested to SpaceX-9
• Launched July 17th, 2016 
Biomolecule Sequencer: the Hardware
Flow Cell: Contains the nanopore sensing technology that is 
required to perform the sequencing reaction
Nanopore-based sequencers measure changes in current caused by DNA 
strands migrating through the pore. The changes in current are characteristic of 
the sequence of migrating DNA. 
Biomolecule Sequencer: the Experiment
Experiment:
• Sequence a ground-prepared sample containing a mixture 
of genomic DNA from:
• Bacteriophage lambda
• Escherichia coli
• Mouse – BALB/C (female)
Goals: 
• Test the basic functionality by 
comparing ISS sequencing results of 
pre-determined samples to ground 
results 
• Evaluate crew operability and potential 
for degrees of autonomy
Biomolecule Sequencer: the Data
August 26th, 2016
“Welcome to systems biology in space.” – Astronaut Kate Rubins, Ph.D.
Biomolecule Sequencer: the Data
On orbit operations: 
August 26, 2016 
September 3, 2016 
September 7, 2016 
September 13, 2016 
October 18, 2016 
October 25, 2016 
October 26, 2016 
November 26, 2016
January 9, 2017 Castro-Wallace et al. http://biorxiv.org/content/early/2016/09/27/077651
Biomolecule Sequencer: 
Current Omics Capabilities 
The “dawn of genomics” in space (Kate Rubins)
• No decrease in sequencing performance 
• Over 284,000 reads were generated on the ISS 
• Directed genome assemblies of: 
• Bacteriophage lambda
• E. coli
• Mouse mitochondrial
• de novo genome assemblies of: 
• Bacteriophage lambda
• E. coli
• Demonstrated flow cell reuse and shelf life stability to 
at least 6 months in space 
Meanwhile on the Ocean Floor…
Swab-to-Sequencer: July 2016
NASA Extreme Environments 
Mission Operations (NEEMO)
A full sample-to-sequencer process on the ocean floor and the 
analog testing of the joint operations of miniPCR and the MinION 
Meanwhile on the Ocean Floor…
The Molecular Space Age 
Genes in Space Program
• “We invite students in grades 7 through 12 to 
design DNA experiments that address challenges in 
space exploration”
• The winner gets:
• mentorship from Zeke and Sebastian (Ph.D.s
from MIT and Harvard)
• miniPCR DNA discovery system for their 
school
• their experiment conducted on the ISS 
Scott Copeland, Boeing
Sebastian Kraves, Ph.D. 
and Ezequiel (Zeke) 
Alvarez Saavedra, Ph.D., 
miniPCR
Genes in Space-1 winner Anna-
Sophia’s investigation was the first 
molecular biology experiment ever 
conducted in space, April 19, 2016
Genes in Space-2 winner 
Julian will have his experiment 
launched to the ISS in March 
2017 on OA-7
Genes in Space moves 
beyond the US with GiS-4 
UAE winner Alia
Just as we are using the ISS as a research platform 
and test bed for exploration, the Genes in Space 
Program is using it to inspire and engage the next 
generation of researchers and explorers. 
https://www.genesinspace.org/
Genes in Space-3
• Will build upon the NEEMO 21 demonstration of the joint operations between miniPCR and the MinION, 
as it will transition the DNA sample preparation process and sequencing to the spaceflight environment
• Enhanced capabilities available to the Genes in Space student contestants (certified reagents, 
consumables, and crew procedures) 
• Increasing the scientific capacity of the ISS
• A series of controlled experiments testing key steps of the DNA preparation process
• Will culminate in the sequencing of unknown environmental samples from the ISS
• Genes in Space-3 is headed to the ISS on Orbital-7
Relative 
abundance and 
identification of all
microbes present 
in a sample 
without prior 
knowledge of the 
sample makeup
The successful implementation of this process will result in, for the first time, the ability to identify contaminating microbes in-flight. 
However, this means so much more than microbiology… 
Current Capabilities
We are working to develop a spaceflight-certified catalogue of general laboratory consumables and 
molecular reagents to be used by ISS researchers. 
Consumables
1.5 ml LoBind Tubes
0.2 ml PCR Tube Strips
Rainin Positive Displacement 
Pipettes: 10 ml, 100 ml, and 1000 
ml and associated tips
Eppendorf Pipettes: 20 ml, 200 ml, 
and 1000 ml and associated tips
MinION Flow Cells
Reagents
PCR Master Mix (NEB) 
Exonuclease (NEB)
Fragmentation Mix (ONT)
Rapid Adaptor Mix (ONT)
Running Buffer (ONT)
Crew Procedure Techniques
Pipetting between numerous vessels
Running a PCR
Using miniPCR as a heat block
Running the MinION 
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All of the operations products have been developed and are available. Reaction conditions for miniPCR and the MinION are easily 
customizable to any experiment. Different enzymes and reactions can be tested with certified consumables and substituted into
procedures. 
Future Capabilities: What can the 
MinION do for your research? 
• Full genome assessments of model organisms
• What is the genomic impact of radiation?
• Complete transcriptomic investigations 
• How is gene expression altered as a result of mission duration? 
• Biomarker tracking through changes in gene expression
• Bone and muscle
• Cardiovascular
• Wound healing
• CO2 exposure
• Direct RNA Sequencing
• How are active transcriptional processes impacted as a result of 
spaceflight culture?
• Epigenetic Studies
• How are methylation patterns affected by the spaceflight 
environment?
How would receiving data from 
your in-flight investigation 
impact your study? 
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